Literature DB >> 17437609

Gelatinolytic activity of matrix metalloproteinase-2 and matrix metalloproteinase-9 in rat brain after implantation of 9L rat glioma cells.

J X Zhao1, L P Yang, Y F Wang, L P Qin, D Q Liu, C X Bai, X Nan, S S Shi, X J Pei.   

Abstract

The matrix metalloproteinases (MMPs) have come to be highlighted by their close relation to the cell invasion of gliomas. The inhibitors of MMPs have undergone extensive development because of its effectiveness against tumor invasion and angiogenesis. Therefore, a suitable animal model is necessary for searching new MMPs inhibitors against gliomas. In this study, we established an experimental model by implanting 9L glioma cells stereotactically into Fisher344 (F344) rat's brain, and the expression and enzymatic activity of MMP-2 and MMP-9 in 9L glioma cells and in tumor tissue was determined by means of reverse transcription polymerase chain reaction (RT-PCR), sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) zymography, in situ film zymography and immunostaining. The results of RT-PCR showed that the mRNA level of MMP-2 in 9L glioma cells was higher than that of MMP-9, and the mRNA expression of MMP-9 was increased along with the growth of malignant gliomas. SDS-PAGE zymography revealed that the expression of MMP-2 and MMP-9 were significantly increased in tumor tissues, and the MMP-9 wasn't detected in normal tissue. The positive stain of MMP-2 and MMP-9 was enhanced with the growth of malignant gliomas, especially for MMP-9. The expression of active gelatinase was found in tumor tissue. In conclusion, the expression of active MMP-2 and MMP-9 was increased in 9L/F344 rat brain during the growth of malignant gliomas at different time intervals, which indicate that 9L/F344 animal model may be a prospective animal model to test new MMPs inhibitors.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17437609     DOI: 10.1111/j.1468-1331.2006.01705.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  7 in total

1.  MMP-2, MMP-9, TIMP-1, and TIMP-2 in the Peripheral Blood of Patients with Differentiated Thyroid Carcinoma.

Authors:  Wen-Jing Zhang; Bing Song; Tao Yang
Journal:  Cancer Manag Res       Date:  2019-12-23       Impact factor: 3.989

Review 2.  Recent advances in the role of toll-like receptors and TLR agonists in immunotherapy for human glioma.

Authors:  Shuanglin Deng; Shan Zhu; Yuan Qiao; Yong-Jun Liu; Wei Chen; Gang Zhao; Jingtao Chen
Journal:  Protein Cell       Date:  2014-11-21       Impact factor: 14.870

3.  Shikonin Inhibits the Migration and Invasion of Human Glioblastoma Cells by Targeting Phosphorylated β-Catenin and Phosphorylated PI3K/Akt: A Potential Mechanism for the Anti-Glioma Efficacy of a Traditional Chinese Herbal Medicine.

Authors:  Feng-Ying Zhang; Yi Hu; Zhong-You Que; Ping Wang; Yun-Hui Liu; Zhen-Hua Wang; Yi-Xue Xue
Journal:  Int J Mol Sci       Date:  2015-10-09       Impact factor: 5.923

4.  Artemether combined with shRNA interference of vascular cell adhesion molecule-1 significantly inhibited the malignant biological behavior of human glioma cells.

Authors:  Ying-Bin Wang; Yi Hu; Zhen Li; Ping Wang; Yi-Xue Xue; Yi-Long Yao; Bo Yu; Yun-Hui Liu
Journal:  PLoS One       Date:  2013-04-11       Impact factor: 3.240

5.  Involvement of Akt/NF-κB pathway in antitumor effects of parthenolide on glioblastoma cells in vitro and in vivo.

Authors:  Hiromichi Nakabayashi; Keiji Shimizu
Journal:  BMC Cancer       Date:  2012-10-05       Impact factor: 4.430

6.  Interleukin-1 receptor antagonist delivered directly and by gene therapy inhibits matrix degradation in the intact degenerate human intervertebral disc: an in situ zymographic and gene therapy study.

Authors:  Christine L Le Maitre; Judith A Hoyland; Anthony J Freemont
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

7.  Polish natural bee honeys are anti-proliferative and anti-metastatic agents in human glioblastoma multiforme U87MG cell line.

Authors:  Justyna Moskwa; Maria H Borawska; Renata Markiewicz-Zukowska; Anna Puscion-Jakubik; Sylwia K Naliwajko; Katarzyna Socha; Jolanta Soroczynska
Journal:  PLoS One       Date:  2014-03-04       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.